BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19941698)

  • 1. Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain.
    Polissidis A; Chouliara O; Galanopoulos A; Rentesi G; Dosi M; Hyphantis T; Marselos M; Papadopoulou-Daifoti Z; Nomikos GG; Spyraki C; Tzavara ET; Antoniou K
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1175-91. PubMed ID: 19941698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Δ(9)-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner.
    Galanopoulos A; Polissidis A; Papadopoulou-Daifoti Z; Nomikos GG; Antoniou K
    Behav Brain Res; 2011 Oct; 224(1):65-72. PubMed ID: 21645556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats.
    Verrico CD; Jentsch JD; Roth RH
    Synapse; 2003 Jul; 49(1):61-6. PubMed ID: 12710016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Dopamine Type 1 Receptors and Dopamine- and cAMP-Regulated Phosphoprotein Mr 32 kDa in Δ9-Tetrahydrocannabinol-Mediated Induction of ΔFosB in the Mouse Forebrain.
    Lazenka MF; Tomarchio AJ; Lichtman AH; Greengard P; Flajolet M; Selley DE; Sim-Selley LJ
    J Pharmacol Exp Ther; 2015 Sep; 354(3):316-27. PubMed ID: 26099530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol.
    Borgkvist A; Marcellino D; Fuxe K; Greengard P; Fisone G
    Neuropharmacology; 2008 Jan; 54(1):31-5. PubMed ID: 17686497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.
    Fanarioti E; Mavrikaki M; Panagis G; Mitsacos A; Nomikos GG; Giompres P
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study.
    Pistis M; Muntoni AL; Pillolla G; Gessa GL
    Eur J Neurosci; 2002 Jun; 15(11):1795-802. PubMed ID: 12081659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats.
    Scherma M; Dessì C; Muntoni AL; Lecca S; Satta V; Luchicchi A; Pistis M; Panlilio LV; Fattore L; Goldberg SR; Fratta W; Fadda P
    Neuropsychopharmacology; 2016 Apr; 41(5):1416-26. PubMed ID: 26388146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure.
    Polissidis A; Chouliara O; Galanopoulos A; Marselos M; Papadopoulou-Daifoti Z; Antoniou K
    Life Sci; 2009 Jul; 85(5-6):248-54. PubMed ID: 19508876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute D-amphetamine.
    Polissidis A; Chouliara O; Galanopoulos A; Naxakis G; Papahatjis D; Papadopoulou-Daifoti Z; Antoniou K
    Behav Brain Res; 2014 Aug; 270():261-9. PubMed ID: 24867330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypocretin/orexin receptor-1 as a novel target to modulate cannabinoid reward.
    Flores Á; Maldonado R; Berrendero F
    Biol Psychiatry; 2014 Mar; 75(6):499-507. PubMed ID: 23896204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.
    Hoffman AF; Oz M; Caulder T; Lupica CR
    J Neurosci; 2003 Jun; 23(12):4815-20. PubMed ID: 12832502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated acetyl-l-carnitine administration increases phospho-Thr34 DARPP-32 levels and antagonizes cocaine-induced increase in Cdk5 and phospho-Thr75 DARPP-32 levels in rat striatum.
    Scheggi S; Rauggi R; Nanni G; Tagliamonte A; Gambarana C
    Eur J Neurosci; 2004 Mar; 19(6):1609-20. PubMed ID: 15066157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro.
    Szabo B; Müller T; Koch H
    J Neurochem; 1999 Sep; 73(3):1084-9. PubMed ID: 10461898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D1 receptor-dependent modifications in the dopamine and cAMP-regulated phosphoprotein of Mr 32 kDa phosphorylation pattern in striatal areas of morphine-sensitized rats.
    Scheggi S; Crociani A; De Montis MG; Tagliamonte A; Gambarana C
    Neuroscience; 2009 Oct; 163(2):627-39. PubMed ID: 19559764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2.
    Morgese MG; Cassano T; Gaetani S; Macheda T; Laconca L; Dipasquale P; Ferraro L; Antonelli T; Cuomo V; Giuffrida A
    Neurochem Int; 2009 Jan; 54(1):56-64. PubMed ID: 19010365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently.
    Polissidis A; Galanopoulos A; Naxakis G; Papahatjis D; Papadopoulou-Daifoti Z; Antoniou K
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):393-403. PubMed ID: 22391102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain.
    Perdikaris P; Tsarouchi M; Fanarioti E; Natsaridis E; Mitsacos A; Giompres P
    Neuropharmacology; 2018 Feb; 129():1-15. PubMed ID: 29113897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.
    Cheer JF; Wassum KM; Heien ML; Phillips PE; Wightman RM
    J Neurosci; 2004 May; 24(18):4393-400. PubMed ID: 15128853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
    Sim LJ; Hampson RE; Deadwyler SA; Childers SR
    J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.